Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection;Adénocarcinomes pancréatiques localement évolués. Chimioradiothérapie, réévaluation et résection secondaire ?

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 462-470

  Delpero, J R ^a   Turrini, O ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Locally advanced pancreatic cancer; Radiochemotherapy; Secondary resection

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER STATISTICS; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXPLORATORY BEHAVIOR; HISTOLOGY; HUMAN; MESENTERY TUMOR; METASTASIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SHORT SURVEY; SUPERIOR MESENTERIC ARTERY; SURVIVAL TIME; TUMOR CELL;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LENGTH OF STAY; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TAXOIDS;

EID: 33750446269     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.07.016     Document Type: Short Survey

References (47)

1. Al-Sukhun S., Zalupski M.M., Ben-Josef E., Vaitkevicius V.K., Philip P.A., Soulen R., et al. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study. Am. J. Clin. Oncol. 26 (2003) 543-549
2. Ammori J.B., Colleti L.M., Zalupski M.M., Eckhauser F.E., Greenson J.K., Dimick J., et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J. Gastrointest. Surg. 7 (2003) 768-772
3. Aristu J., Canon R., Pardo F., Martínez-Monge R., Martin-Algarra S., Manuel Ordoñez J., et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am. J. Clin. Oncol. 26 (2003) 30-36
4. Bettini N., Moutardier V., Turrini O., Bories E., Monges G., Giovannini M., et al. Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation. Gastroenterol. Clin. Biol. 29 (2005) 659-663
5. Chao C., Hoffman J.P., Ross E.A., Torosian M.H., and Eisenberg B.L. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience. Am. Surg. 66 (2000) 378-386
6. Cheng T.Y., Sheth K., White R.R., Ueno T., Hung C.F., Clary B.M., et al. Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann. Surg. Oncol. 13 (2006) 66-74
7. Crane C.H., Abbruzzese J.L., Evans D.B., Wolff R.A., Ballo M.T., Delclos M., et al. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil- based chemoradiation in locally advanced pancreatic cancer?. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 1293-1302
8. Evans D.B., Rich T.A., Byrd D.R., Cleary K.R., Connelly J.H., Levin B., et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch. Surg. 127 (1992) 1335-1339
9. Evans D.B., Pisters P.W., Lee J.E., Bold R.J., Charnsangavej C., Janjan N.A., et al. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J. Hepatobiliary Pancreat. Surg. 5 (1998) 242-250
10. Evans D.B. Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. J. Gastrointest. Surg. 5 (2001) 2-5
11. Fuhrman G.M., Leach S.D., Staley C.A., Cusack J.C., Charnsangavej C., Cleary K.R., et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann. Surg. 223 (1996) 154-162
12. Hoffman J. Does prior adjuvant chemoradiotherapy lead to a safer pancreatoduodenectomy?. Ann. Surg. Oncol. 13 (2006) 7-9
13. Ishikawa O., Ohigashi H., Imaoka S., Furukawa H., Sasaki Y., Fujita M., et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann. Surg. 215 (1992) 231-236
14. Ishikawa O., Ohhigashi H., Teshima T., Ishikawa O., Ohhigashi H., Teshima T., et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J. Surg. Oncol. 40 (1989) 143-151
15. Kastl S., Brunner T., Herrmann O., Riepl M., Fietkau R., Grabenbauer G., et al. Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas. Eur. J. Surg. Oncol. 26 (2000) 578-582
16. Kim H.J., Czischke K., Brennan M.F., and Conlon K.C. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J. Gastrointest. Surg. 6 (2002) 763-769
17. Magnin V., Moutardier V., Giovannini M.H., Lelong B., Giovannini M., Viret F., et al. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 1300-1304
18. Maire F., Sauvanet A., Trivin F., Hammel P., O'Toole D., Palazzo L., et al. Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: an indirect evaluation of the usefulness of laparoscopy. Pancreatol. 4 (2004) 436-440
19. Mehta V.K., Fisher G., Ford J.A., Poen J.C., Vierra M.A., Oberhelman H., et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J. Gastrointest. Surg. 5 (2001) 27-35
20. Miller A.R., Pisters P.W., Lee J.E., Janjan N.A., Abbruzzese J.L., and Evans D.B. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 45 (1998) 624-633
21. Miller A.R., Robinson E.K., Lee J.E., Pisters P.W., Chiao P.J., Lenzi R.L., et al. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg. Oncol. Clin. N. Am. 7 (1998) 183-197
22. Mitsunaga S., Hasebe T., Iwasaki M., Kinoshita T., Ochiai A., and Shimizu N. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci. 96 (2005) 858-865
23. Mornex F., Girard N., Delpero J.R., and Partensky C. Radiochemotherapy in the management of pancreatic cancer-part I: neoadjuvant treatment. Semin. Radiat. Oncol. 15 (2005) 226-234
24. Mornex F, Le Scodan R, Partensky C, Ychou M, Scoazec J. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French phase II FFCD 9704-SFR0 trial. American Society of Clinical Oncology; 2006 Gastrointestinal Cancers Symposium; Abstract No: 120.
25. Nix G.A., Dubbelman C., Srivastava E.D., Wilson J.H., Boender J., and de Jongh F.E. Prognostic implications of the localization of carcinoma in the head of the pancreas. Am. J. Gastroenterol. 86 (1991) 1027-1032
26. Ohigashi H., Ishikawa O., Eguchi H., Sasaki Y., Yamada T., Noura S., et al. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head. Ann. Surg. Oncol. Oncol. 12 (2005) 629-636
27. Pingpank J.F., Hoffman J.P., Ross E.A., Cooper H.S., Meropol N.J., Freedman G., et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J. Gastrointest. Surg. 5 (2001) 121-130
28. Pipas J.M., Barth Jr. R.J., Zaki B., Tsapakos M.J., Suriawinata A.A., Bettmann M.A., et al. Docetaxel-Gemcitabine folowed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. Ann. Surg. Oncol. 12 (2005) 995-1004
29. Pisters P.W., Wolff R.A., Janjan N.A., Cleary K.R., Charnsangavej C., Crane C.N., et al. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J. Clin. Oncol. 20 (2002) 2537-2544
30. Robinson E.K., Lee J.E., Lowy A.M., Fenoglio C.J., Pisters P.W., and Evans D.B. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am. J. Surg. 172 (1996) 432-437
31. Sa Cunha A., Rault A., Laurent C., Adhoute X., Vendrely V., Bellannee G., et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J. Am. Coll. Surg. 201 (2005) 359-365
32. Sasson A.R., Wetherington R.W., Hoffman J.P., Ross E.A., Cooper H., Meropol N.J., et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. Int. J. Gastrointest. Cancer 34 (2003) 121-128
33. Sasson A.R., Hoffman J.P., Ross E.A., Kagan S.A., Pingpank J.F., and Eisenberg B.L. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?. J. Gastrointest. Surg. 6 (2002) 147-158
34. Snady H., Bruckner H., Cooperman A., Paradiso J., and Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 89 (2000) 314-327
35. Sohn T.A., Lillemoe K.D., Cameron J.L., Pitt H.A., Huang J.J., Hruban R.H., et al. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. Ann. Surg. 229 (1999) 393-400
36. Spitz F.R., Abbruzzese J.L., Lee J.E., Spitz F.R., Abbruzzese J.L., Lee J.E., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J. Clin. Oncol. 15 (1997) 928-937
37. Staley C.A., Cleary K.R., Abbruzzese J.L., Staley C.A., Cleary K.R., Abbruzzese J.L., et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12 (1996) 373-380
38. Tseng J.F., Raut C.P., Lee J.E., Pisters P.W., Vauthey J.N., Abdalla E.K., et al. Pancreaticoduodenectomy with vascular resection: Margin status and survival duration. J. Gastrointest. Surg. 8 (2004) 935-950
39. Varadhachary G.R., Tamm E.P., Crane C., Evans D.B., and Wolff R.A. Borderline resectable pancreatic cancer. Curr. Treat. Options Gastroenterol. 8 (2005) 377-384
40. Viret F., Ychou M., Moutardier V., Magnin V., Rouanet P., Monges G., et al. Preoperative radiotherapy and docetaxel in resectable pancreatic adenocarcinoma: a phase II trial. J. Clin. Oncol. 24 (2006) 18S (2006 ASCO Annual Meeting Proceedings)
41. Wanebo H.J., Glicksman A.S., Vezeridis M.P., Clark J., Tibbetts L., Koness R.J., et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch. Surg. 135 (2000) 81-87
42. White R.R., Paulson E.K., Freed K.S., Keogan M.T., Hurwitz H.I., Lee C., et al. Staging of pancreatic cancer before and after neoadjuvant chemoradiation. Gastrointest. Surg. 5 (2001) 626-633
43. White R.R., Hurwitz H.I., Morse M.A., Lee C., Anscher M.S., Paulson E.K., et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann. Surg. Oncol. 8 (2001) 758-765
44. White R.R., Xie H.B., Gottfried M.R., Czito B.G., Hurwitz H.I., Morse M.A., et al. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann. Surg. Oncol. 12 (2005) 214-221
45. Wilkowski R., Thoma M., Schauer R., Wagner A., and Heinemann V. Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer. World J. Surg. 28 (2004) 1011-1018
46. Wolff R.A. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas: great logic, grim reality. Ann. Surg. Oncol. 8 (2001) 747-748
47. Wolff R.A., Evans D.B., Gravel D.M., Lenzi R., Pisters P.W., Lee J.E., et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin. Cancer Res. 7 (2001) 2246-2253